North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19

In our Hospital all patients are phoned screened the evening before treatment & a strict protocol is followed ie re immunoglobulin , IR and Covid swabed 24 hrs pre Bronchoscopy via the rapid access clinic.

RT @Rubankhan18: Very good article reflecting how health care providers are affected in addition to the patients. https://t.co/lAh3ym…

Very good article reflecting how health care providers are affected in addition to the patients. https://t.co/lAh3ymATI8

RT @CureNETs: @NANETS1 Guide to #NETcancer patient healthcare during #COVID19 by @PamelaKunzMD @dmhalperin @helops79 @lisabodei @adasarimd…

@NANETS1 Guide to #NETcancer patient healthcare during #COVID19 by @PamelaKunzMD @dmhalperin @helops79 @lisabodei @adasarimd @Globeseek et al in @PANCREASonline https://t.co/YS84XVRKf2 https://t.co/PxG2JHVwew

RT @NeuroendocrinoS: #NANET #guidelines en tiempos de #COVID19 https://t.co/aGm5lVrBDz https://t.co/ps5oOAvrcj

@paulendocrino

RT @NeuroEndoTalk: #NANETS guidelines for #NET health care providers in times of #COVID19: Does COVID19 change treatment plans? Should you…

RT @NeuroendocrinoS: #NANET #guidelines en tiempos de #COVID19 https://t.co/aGm5lVrBDz https://t.co/ps5oOAvrcj

#NANET #guidelines en tiempos de #COVID19 https://t.co/aGm5lVrBDz https://t.co/ps5oOAvrcj

RT @NeuroEndoTalk: #NANETS guidelines for #NET health care providers in times of #COVID19: Does COVID19 change treatment plans? Should you…

RT @CarcinoidNETs: Guidelines from @NANETS1 for health care providers treating #NeuroendocrineTumor patients during #COVID19. @PamelaKunzMD…

RT @NeuroEndoTalk: #NANETS guidelines for #NET health care providers in times of #COVID19: Does COVID19 change treatment plans? Should you…

RT @CarcinoidNETs: Guidelines from @NANETS1 for health care providers treating #NeuroendocrineTumor patients during #COVID19. @PamelaKunzMD…

Honored to be a member of this working group who came together and issued this guidance quickly in the early days of the pandemic. Here is the video discussion of this article https://t.co/M6lSSCGdpj

RT @NeuroEndoTalk: #NANETS guidelines for #NET health care providers in times of #COVID19: Does COVID19 change treatment plans? Should you…

Guidelines from @NANETS1 for health care providers treating #NeuroendocrineTumor patients during #COVID19. @PamelaKunzMD @helops79 @Globeseek @adasarimd @lisabodei

#NANETS guidelines for #NET health care providers in times of #COVID19: Does COVID19 change treatment plans? Should you delay #SSA or #PRRT treatment? Should you delay surgeries? A lot of very important questions were answered by experts in the NET fiel…

RT @NeuroEndoTalk: NANETS #COVID Guidelines #3. SSAs: Should octreotide or lanreotide be delayed or stopped in #NET? “The balance of potent…

NANETS #COVID Guidelines #3. SSAs: Should octreotide or lanreotide be delayed or stopped in #NET? “The balance of potential harms that may result from delaying or interrupting SSA treatment ... in NET patients is very uncertain”. #LetsTalkAboutNETs https…

RT @NeuroEndoTalk: @CarcinoidNETs @NVijayvergiaMD @FoxChaseCancer Little is known about #COVID19 and #NETs. The North American Neuroendocri…

@CarcinoidNETs @NVijayvergiaMD @FoxChaseCancer Little is known about #COVID19 and #NETs. The North American Neuroendocrine Tumor Society has provided some guidelines that range from postponing surgery to potential issues with Everolimus. Download the ar…

North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19

About this Attention Score

Mentioned by

Readers on